Non-small cell lung cancer

ROMIPLOSTIM

DEXAMETHASONE

DOMVANALIMAB; PEMBROLIZUMAB; ZIMBERELIMAB

N-[2-[2-(DIMETHYLAMINO)ETHYL-METHYLAMINO]-5-[[4-(1-METHYLINDOL-3-YL)PYRIMIDIN-2-YL]AMINO]-6-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-3-YL]PROP-2-ENAMIDE

DATOPOTAMAB DERUXTECAN; PEMBROLIZUMAB; RILVEGOSTOMIG

DURVALUMAB

DURVALUMAB

OSIMERTINIB

3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE; BAY 2927088; CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; PEMETREXED; SEVABERTINIB

CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; PEMETREXED; ZONGERTINIB

ATEZOLIZUMAB; DURVALUMAB; NIVOLUMAB; PEMBROLIZUMAB; ZONGERTINIB

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IPILIMUMAB; NIVOLUMAB; PACLITAXEL; PEMETREXED; VINORELBINE; VINORELBINE TARTRATE

CARBOPLATIN; CISPLATIN; DOCETAXEL; NIVOLUMAB; PACLITAXEL; PEMETREXED

CRIZOTINIB; REPOTRECTINIB

PUMITAMIG

DATOPOTAMAB DERUXTECAN; PEMBROLIZUMAB

DATOPOTAMAB DERUXTECAN; PEMBROLIZUMAB

DATOPOTAMAB DERUXTECAN

ATEZOLIZUMAB; TIRAGOLUMAB

ALECTINIB; DURVALUMAB

ATEZOLIZUMAB; CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL ALBUMIN-BOUND; PEMETREXED

ALECTINIB; ALECTINIB HYDROCHLORIDE; ATEZOLIZUMAB; CABOZANTINIB; COBIMETINIB; NIRAPARIB; PACLITAXEL; PEMETREXED; SUNITINIB; VEMURAFENIB; VENETOCLAX

ATEZOLIZUMAB

CRIZOTINIB; ENTRECTINIB

DOCETAXEL; SACITUZUMAB GOVITECAN

NIRAPARIB TOSILATE MONOHYDRATE; PEMBROLIZUMAB

AMIVANTAMAB; CARBOPLATIN; PEMETREXED

AMIVANTAMAB; LAZERTINIB; OSIMERTINIB

AMIVANTAMAB; LAZERTINIB

2-AMINO-9-((2R,4R,5R)-4-HYDROXY-5-(HYDROXYMETHYL) TETRAHYDROFURAN-2-YL)-1,4,5,9-TETRAHYDRO-6H-PURINE-6-THIONE; CEMIPLIMAB; DOCETAXEL; GEMCITABINE; VINORELBINE

PEMBROLIZUMAB

SACITUZUMAB TIRUMOTECAN

MRNA-4157; PEMBROLIZUMAB

MRNA-4157; PEMBROLIZUMAB

PEMBROLIZUMAB

ADAGRASIB; DOCETAXEL

1-{6-[(4M)-4-(5-CHLORO-6-METHYL-1H -INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H -INDAZOL-5-YL)-1H -PYRAZOL-1-YL]-2-AZASPIRO[3.3]HEPTAN-2-YL}PROP-2-EN-1-ONE

ALECTINIB HYDROCHLORIDE; NVL-655

PEMBROLIZUMAB; SIGVOTATUG VEDOTIN

HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER

PEMBROLIZUMAB

CARBOPLATIN; CEMIPLIMAB; CISPLATIN; IPILIMUMAB; PACLITAXEL; PEMETREXED

CARBOPLATIN; CEMIPLIMAB; CISPLATIN; GEMCITABINE; PACLITAXEL; PEMETREXED

(12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE

SIGVOTATUG VEDOTIN

CARBOPLATIN; CISPLATIN; PEMETREXED; ZIPALERTINIB

CARBOPLATIN; CISPLATIN; PEMETREXED; ZIPALERTINIB

OSIMERTINIB

DURVALUMAB

CEMIPLIMAB

SACITUZUMAB GOVITECAN; ZIMBERELIMAB

SODIUM CHLORIDE; TISLELIZUMAB

TELISOTUZUMAB ADIZUTECAN

TELISOTUZUMAB ADIZUTECAN

IZALONTAMAB BRENGITECAN

COBOLIMAB; DOCETAXEL; DOSTARLIMAB

ADAGRASIB; PEMBROLIZUMAB

CEMIPLIMAB; FIANLIMAB

TELISOTUZUMAB VEDOTIN

AMG 193

DURVALUMAB; INFLIXIMAB; MYCOPHENOLATE MOFETIL

DATOPOTAMAB DERUXTECAN; DURVALUMAB; INFLIXIMAB; MYCOPHENOLATE MOFETIL; OSIMERTINIB; SELUMETINIB

OSIMERTINIB

DURVALUMAB; OLAPARIB

RILVEGOSTOMIG

FARLETUZUMAB ECTERIBULIN

AZACITIDINE

DATOPOTAMAB DERUXTECAN

BNT324; BNT327; HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST TROP2 CONJUGATED TO N-((7S,15S)-7-BENZYL-17-(((1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL-10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12H-BENZO[DE]PYRANO[3',4':6,7] INDOLIZINO[1,2-B]QUINOLIN-1-YL)AMINO)-15-METHYL-2,5,8,11,17-PENTAOXO-14-OXA-3,6,9,12-TETRAAZAHEPTADECYL)-6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANAMIDE

ALECTINIB; CARBOPLATIN; CISPLATIN; PEMETREXED

ATEZOLIZUMAB; TIRAGOLUMAB

ACASUNLIMAB; PEMBROLIZUMAB

CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; SACITUZUMAB GOVITECAN

CARBOPLATIN; CISPLATIN; DOSTARLIMAB; PEMBROLIZUMAB; PEMETREXED

INCB099280

AUTOLOGOUS TUMOUR-INFILTRATING LYMPHOCYTES; CYCLOPHOSPHAMIDE; FLUDARABINE PHOSPHATE; LIFILEUCEL; PEMBROLIZUMAB

AMIVANTAMAB; LAZERTINIB

AMIVANTAMAB; DEXAMETHASONE; LAZERTINIB; METHOTREXATE; MONTELUKAST SODIUM

ZANIDATAMAB

HAFNIUM OXIDE

2-AMINO-9-((2R,4R,5R)-4-HYDROXY-5-(HYDROXYMETHYL) TETRAHYDROFURAN-2-YL)-1,4,5,9-TETRAHYDRO-6H-PURINE-6-THIONE; CEMIPLIMAB

PEMBROLIZUMAB

PEMBROLIZUMAB; PETOSEMTAMAB

ADAGRASIB

177LU-FAP-2286; CALCIUM FOLINATE; FAP-2286; PACLITAXEL ALBUMIN-BOUND

1-{6-[(4M)-4-(5-CHLORO-6-METHYL-1H -INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H -INDAZOL-5-YL)-1H -PYRAZOL-1-YL]-2-AZASPIRO[3.3]HEPTAN-2-YL}PROP-2-EN-1-ONE

BINIMETINIB; ENCORAFENIB

CEMIPLIMAB; ENOMIMERAN, RBL005.3, RBL007.2, RBL012.2, RBL027.2, RBL035.2

CEMIPLIMAB; CEMIPLIMAB, FIANLIMAB

CARBOPLATIN; CEMIPLIMAB; CISPLATIN; PACLITAXEL; PEMETREXED; REGN7075

(12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE; (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE

(2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE

PEMBROLIZUMAB; TISOTUMAB VEDOTIN

DISITAMAB VEDOTIN

HLX43

SKB264

CARBOPLATIN; PEMBROLIZUMAB; PEMETREXED; STK-012

DEXTROMETHORPHAN; DIGOXIN; MIDAZOLAM; ROSUVASTATIN; ZIPALERTINIB

(R)-6-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-N-(3-ETHYNYL-2-FLUOROPHENYL)-7-METHOXYQUINAZOLIN-4-AMINE-FUMARATE (2:1)

OSIMERTINIB

SACITUZUMAB GOVITECAN; ZIMBERELIMAB

CERALASERTIB; MONALIZUMAB; OLECLUMAB; SAVOLITINIB

ADAGRASIB

DURVALUMAB; TREMELIMUMAB

AMIVANTAMAB; BEVACIZUMAB; LAZERTINIB

DACOMITINIB; OSIMERTINIB

CABOZANTINIB

CEMIPLIMAB; MPS-112, MPS-106, MPS-213, MPS-102, MPS-216, MPS-103, MPS-215, MPS-214, D-ALA-LYS-CHA-VAL-ALA-ALA-TRP-THR-LEU-LYS-ALA-ALA-D-ALA, MPS-200; PEMETREXED

AMIVANTAMAB; PEMETREXED

BRIGATINIB; CERITINIB

NIVOLUMAB

IPILIMUMAB; NIVOLUMAB

ATEZOLIZUMAB

CARBOPLATIN; CEMIPLIMAB; PACLITAXEL; PEMETREXED

CARBOPLATIN; DURVALUMAB; PACLITAXEL; RIFAXIMIN

SOTORASIB

ALLOGENEIC FAECAL MICROBIOTA, POOLED; CEMIPLIMAB

NIVOLUMAB; RELATLIMAB

OSIMERTINIB

BUDIGALIMAB; CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; PEMETREXED; TELISOTUZUMAB ADIZUTECAN

AMG 193; IDE397

APL-101

BEMCENTINIB

BNT326; BNT327

NIVOLUMAB

NIVOLUMAB; NIVOLUMAB, RELATLIMAB; RELATLIMAB

CYC140 MONOHYDROCHLORIDE MONOHYDRATE

FARLETUZUMAB ECTERIBULIN; LENVATINIB

BUDESONIDE; CARBOPLATIN; CISPLATIN; DIVARASIB; PEMBROLIZUMAB; PEMETREXED

ADAGRASIB; INCB099280

CEMIPLIMAB; SYM023; SYM024; SYM025

ANHYDROUS DOCETAXEL; DOSTARLIMAB; ROGINOLISIB

AMIVANTAMAB; CAPMATINIB

1-{6-[(4M)-4-(5-CHLORO-6-METHYL-1H -INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H -INDAZOL-5-YL)-1H -PYRAZOL-1-YL]-2-AZASPIRO[3.3]HEPTAN-2-YL}PROP-2-EN-1-ONE; RIBOCICLIB; TRAMETINIB; TRAMETINIB DIMETHYL SULFOXIDE

AVUTOMETINIB; DEFACTINIB; SOTORASIB

CARBOPLATIN; PEMBROLIZUMAB; PEMETREXED; VUDALIMAB

SODIUM CHLORIDE; TREMELIMUMAB

DURVALUMAB

DABRAFENIB MESYLATE; TRAMETINIB

CALCIUM FOLINATE

CLDN6 CAR-T; CLDN6 CAR-T(A); CLDN6 RNA-LPX; RBP030.2

SGN-ALPV

DATOPOTAMAB DERUXTECAN; DURVALUMAB; RILVEGOSTOMIG; SABESTOMIG; VOLRUSTOMIG

CERALASERTIB; DURVALUMAB; DURVALUMAB, HYALURONIDASE (HUMAN RECOMBINANT); TREMELIMUMAB

2-(5-BROMOPYRIDIN-3-YL)SULFANYL-6-(HYDROXYMETHYL)-4-[4-(3,4,5-TRIFLUOROPHENYL)TRIAZOL-1-YL]OXANE-3,5-DIOL; 5-BROMOPYRIDIN-3-YL 3-DEOXY-1-THIO-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-ALFA-D-GALACTOPYRANOSIDE

(12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE; CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; PEMETREXED; RMC-6291

(12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE; CARBOPLATIN; CISPLATIN; PEMBROLIZUMAB; PEMETREXED

[14C]ZIPALERTINIB

LETETRESGENE AUTOLEUCEL

AMG 193

LBL-007; SURZEBICLIMAB; TISLELIZUMAB

BNT142

BMS-986442; NIVOLUMAB

CR-001

DS-3939A

DCC-3116; SOTORASIB

AKKERMANSIA MUCINIPHILA, STRAIN P2261, LIVE; ATEZOLIZUMAB; CEMIPLIMAB; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB

BEVACIZUMAB; CAPECITABINE; DOXORUBICIN HYDROCHLORIDE; FULVESTRANT; GTAEXS617; PACLITAXEL

1-{6-[(4M)-4-(5-CHLORO-6-METHYL-1H -INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H -INDAZOL-5-YL)-1H -PYRAZOL-1-YL]-2-AZASPIRO[3.3]HEPTAN-2-YL}PROP-2-EN-1-ONE; BATOPROTAFIB; TISLELIZUMAB

ALLOGENEIC PLASMACYTOID DENDRITIC CELLS, LOADED WITH SEVEN LUNG TUMOR ANTIGEN-DERIVED PEPTIDES, IRRADIATED; PEMBROLIZUMAB; PEMETREXED

DAVUTAMIG

JK08; LENVATINIB; PEMBROLIZUMAB

JK06

TAS3351